A multi-cohort investigation of the effects of BDNF Val66Met on tau, neurodegeneration and cognition in preclinical Alzheimer’s disease [ 2018 - ]

Research Grant

Researchers: Dr Yen Ying Lim (Principal investigator)

Brief description There are currently no disease modifying therapies for Alzheimer’s disease. We will elucidate the role of a genetic polymorphism that has previously been shown to exert neuroprotective effects on memory decline and brain volume loss associated with Alzheimer’s disease. By studying the role of this gene in multiple cohorts of individuals with varying degrees of Alzheimer’s disease risk, this study has high potential to uncover novel disease-modifying strategies for the treatment of the disease.

Funding Amount $321,261.00

Funding Scheme Project Grants

Notes New Investigator Grant